Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Lopez Bernal, Jamie; Andrews, Nick; Gower, Charlotte; Gallagher, Eileen; Simmons, Ruth; Thelwall, Simon; Stowe, Julia; Tessier, Elise; Groves, Natalie; Dabrera, Gavin; Myers, Richard; Campbell, Colin; Amirthalingam, Gayatri; Edmunds, Matt; Zambon, Maria; Brown, Kevin; Hopkins, Susan; Chand, Meera; Ramsay, Mary

doi:10.1056/nejmoa2108891

Public

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Published in New England Journal of Medicine • Jul 21, 2021

Authors:

Jamie Lopez Bernal

Nick Andrews

Charlotte Gower

Abstract

BACKGROUND: The B.1.617.2 (delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has contributed to a surge in cases in India and has now been detected across the globe, including a notable increase in cases in ...

Subject

Vaccination

Medicine

Coronavirus disease 2019 (COVID-19)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!